225 related articles for article (PubMed ID: 35125814)
1. Novel technologies in cfDNA analysis and potential utility in clinic.
Li J; Xu M; Peng J; Wang J; Zhao Y; Wu W; Lan X
Chin J Cancer Res; 2021 Dec; 33(6):708-718. PubMed ID: 35125814
[TBL] [Abstract][Full Text] [Related]
2. Cell-Free DNA Methylation Profiling Analysis-Technologies and Bioinformatics.
Huang J; Wang L
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31698791
[TBL] [Abstract][Full Text] [Related]
3. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
4. Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook.
Ng CKY; Di Costanzo GG; Terracciano LM; Piscuoglio S
Front Med (Lausanne); 2018; 5():78. PubMed ID: 29632864
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer.
Chan RH; Lin PC; Chen SH; Lin SC; Chen PC; Lin BW; Shen MR; Yeh YM
Front Oncol; 2021; 11():589673. PubMed ID: 33816227
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
7. Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors.
McEwen AE; Leary SES; Lockwood CM
Front Cell Dev Biol; 2020; 8():45. PubMed ID: 32133357
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer.
Huang CC; Du M; Wang L
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212602
[TBL] [Abstract][Full Text] [Related]
9. Computational challenges in detection of cancer using cell-free DNA methylation.
Sharma M; Verma RK; Kumar S; Kumar V
Comput Struct Biotechnol J; 2022; 20():26-39. PubMed ID: 34976309
[TBL] [Abstract][Full Text] [Related]
10. IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
Deans ZC; Butler R; Cheetham M; Dequeker EMC; Fairley JA; Fenizia F; Hall JA; Keppens C; Normanno N; Schuuring E; Patton SJ
Virchows Arch; 2019 Jun; 474(6):681-689. PubMed ID: 31028539
[TBL] [Abstract][Full Text] [Related]
11. Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects.
García-Ortiz MV; Cano-Ramírez P; Toledano-Fonseca M; Aranda E; Rodríguez-Ariza A
Biomark Res; 2023 Oct; 11(1):88. PubMed ID: 37798621
[TBL] [Abstract][Full Text] [Related]
12. Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer.
Maltoni R; Palleschi M; Ravaioli S; Tumedei MM; Rocca A; Melegari E; Altini M; Puccetti M; Manunta S; Bravaccini S
Cell Transplant; 2020; 29():963689720925057. PubMed ID: 32584148
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in early stage lung cancer.
Pérez-Ramírez C; Cañadas-Garre M; Robles AI; Molina MÁ; Faus-Dáder MJ; Calleja-Hernández MÁ
Transl Lung Cancer Res; 2016 Oct; 5(5):517-524. PubMed ID: 27826533
[TBL] [Abstract][Full Text] [Related]
14. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
Thierry AR
Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
[TBL] [Abstract][Full Text] [Related]
15. The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
Van Paemel R; Vandeputte C; Raman L; Van Thorre J; Willems L; Van Dorpe J; Van Der Linden M; De Wilde J; De Koker A; Menten B; Devalck C; Vicha A; Grega M; Schleiermacher G; Iddir Y; Chicard M; van Zogchel L; Stutterheim J; Lak NSM; Tytgat GAM; Laureys G; Speleman F; De Wilde B; Lammens T; De Preter K; Van Roy N
Eur J Cancer; 2022 Jan; 160():12-23. PubMed ID: 34794856
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring.
Qi F; Cao Z; Chen B; Chai Y; Lin J; Ye J; Wei Y; Liu H; Han-Zhang H; Mao X; Feng X; Dong M
Blood Adv; 2021 Jun; 5(11):2505-2514. PubMed ID: 34047776
[TBL] [Abstract][Full Text] [Related]
17. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A
Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy with cell free DNA: new horizons for prostate cancer.
Ponti G; Maccaferri M; Percesepe A; Tomasi A; Ozben T
Crit Rev Clin Lab Sci; 2021 Jan; 58(1):60-76. PubMed ID: 32805148
[TBL] [Abstract][Full Text] [Related]
19. Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma.
Chicard M; Boyault S; Colmet Daage L; Richer W; Gentien D; Pierron G; Lapouble E; Bellini A; Clement N; Iacono I; Bréjon S; Carrere M; Reyes C; Hocking T; Bernard V; Peuchmaur M; Corradini N; Faure-Conter C; Coze C; Plantaz D; Defachelles AS; Thebaud E; Gambart M; Millot F; Valteau-Couanet D; Michon J; Puisieux A; Delattre O; Combaret V; Schleiermacher G
Clin Cancer Res; 2016 Nov; 22(22):5564-5573. PubMed ID: 27440268
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer.
Liu X; Liu L; Ji Y; Li C; Wei T; Yang X; Zhang Y; Cai X; Gao Y; Xu W; Rao S; Jin D; Lou W; Qiu Z; Wang X
EBioMedicine; 2019 Mar; 41():345-356. PubMed ID: 30857943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
